日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

接受马伐卡坦治疗的梗阻性肥厚型心肌病患者发生房颤和收缩功能障碍的概率及预后:一项多中心研究

Nguyen, Olives; Wiedrick, Jack; Massera, Daniele; Adlestein, Elizabeth; Frejat, Sumar; Castrichini, Matteo; Alsidawi, Said; Giudicessi, John R; Geske, Jeffrey B; Carrick, Richard T; Madrazo, Jose; Dellise, Nicole; Zenker, Mark A; Boyle, Thomas A; Reza, Nosheen; Owens, Anjali Tiku; Frankel, David S; Hundal, Prabhjot; Tajik, Jamil; Galazka, Patrycja; Lewontin, Myra; Ayers, Michael; Wong, Timothy; Flanagan, Michael; Mitter, Sumeet Singh; Kanwal, Arjun; Bilen, Ozlem; Baghdadi, Sarah; Shah, Hirak; Kvapil, Jared; Roldan, Paola; Berenbom, Loren; Jesurum, Jill; Tootill, Denise; Siqueira-Benzow, Alice; Harper, Mariko; Saleh, Danish; Choudhury, Lubna; Valenta, Isabela; Lang, Melissa; Phelan, Dermot M; Prizand, Dmitry; Lakdawala, Neal; Ho, Carolyn Y; Liang, Lusha W; Weiner, Shepard D; Ravi, Sririam; Abuzaid, Ahmed Sami; Makkiya, Mohammed; Markowitz, Jeremy S; Sherrid, Mark; Masri, Ahmad

Left Atrial Appendage Thrombus in Hypertrophic Cardiomyopathy With Atrial Fibrillation-Common and Resistant to Treatment

肥厚型心肌病合并房颤患者左心耳血栓——常见且难治

Massera, Daniele; Sherrid, Mark V

Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten

致编辑的信,内容关于:接受马伐卡门治疗的梗阻性肥厚型心肌病患者出现灾难性心尖球形扩张。

Sherrid, Mark V; Kim, Bette; Massera, Daniele

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Mavacamten治疗接受室间隔减容术的肥厚型心肌病患者:VALOR-HCM研究第128周结果

Desai, Milind Y; Wolski, Kathy; Owens, Anjali; Geske, Jeffrey B; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C; Lakdawala, Neal K; Tower-Rader, Albree; Fermin, David; Naidu, Srihari S; Smedira, Nicholas G; Schaff, Hartzell; Gong, Zhiqun; Mudarris, Lana; Lampl, Kathy; Sehnert, Amy J; Nissen, Steven E

Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy

MAVA-长期扩展心脏磁共振成像子研究EXPLORER队列中梗阻性肥厚型心肌病患者对Mavacamten的治疗反应:96周结果

Saberi, Sara; Kramer, Christopher M; Oręziak, Artur; Masri, Ahmad; Barriales-Villa, Roberto; Abraham, Theodore P; Lakdawala, Neal K; Wang, Andrew; Choudhury, Lubna; Rader, Florian; Havakuk, Ofer; Stendahl, John C; Cardim, Nuno; Seidler, Tim; Sherrid, Mark; Hegde, Sheila M; Kwong, Raymond Y; Jerosch-Herold, Michael; Balaratnam, Ganesh; Kurio, Gregory; Fox, Shawna; Olivotto, Iacopo; Owens, Anjali

Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years

重新评估丙吡胺治疗症状性梗阻性肥厚型心肌病的疗效:至少接受 5 年治疗的患者的疗效和安全性

Massera, Daniele; Sherrid, Mark V; Adlestein, Elizabeth; Bokhari, Nadia; Alvarez, Isabel C; Wu, Woon Y; Reuter, Maria C; Maron, Martin S; Maron, Barry J; Rowin, Ethan J

Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy

Mavacamten 用于对既往高级疗法无效的梗阻性肥厚型心肌病症状患者

Massera, Daniele; Adlestein, Elizabeth; Frejat, Sumar; Wu, Woon Y; Reuter, Maria C; Xia, Yuhe; Alvarez, Isabel C; Sherrid, Mark V

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

接受马伐卡坦治疗的梗阻性肥厚型心肌病患者发生房颤和收缩功能障碍的概率及预后:一项多中心研究

Nguyen, Olives; Wiedrick, Jack; Massera, Daniele; Adlestein, Elizabeth; Frejat, Sumar; Castrichini, Matteo; Alsidawi, Said; Giudicessi, John R; Geske, Jeffrey B; Carrick, Richard T; Madrazo, Jose; Dellise, Nicole; Zenker, Mark A; Boyle, Thomas A; Reza, Nosheen; Owens, Anjali Tiku; Frankel, David S; Hundal, Prabhjot; Tajik, Jamil; Galazka, Patrycja; Lewontin, Myra; Ayers, Michael; Wong, Timothy; Flanagan, Michael; Mitter, Sumeet Singh; Kanwal, Arjun; Bilen, Ozlem; Baghdadi, Sarah; Shah, Hirak; Kvapil, Jared; Roldan, Paola; Berenbom, Loren; Jesurum, Jill; Tootill, Denise; Siqueira-Benzow, Alice; Harper, Mariko; Saleh, Danish; Choudhury, Lubna; Valenta, Isabela; Lang, Melissa; Phelan, Dermot M; Prizand, Dmitry; Lakdawala, Neal; Ho, Carolyn Y; Liang, Lusha W; Weiner, Shepard D; Ravi, Sririam; Abuzaid, Ahmed Sami; Makkiya, Mohammed; Markowitz, Jeremy S; Sherrid, Mark; Masri, Ahmad

Covert Transthyretin Amyloidosis Mimicking Advanced Obstructive Hypertrophic Cardiomyopathy Despite Multiple Negative (99m)Tc-PYP Radionuclide Scans

隐匿性转甲状腺素蛋白淀粉样变性,尽管多次(99m)Tc-PYP放射性核素扫描结果均为阴性,却表现为晚期梗阻性肥厚型心肌病

Reuter, Maria; Wu, Woon; Massera, Daniele; Phillips, Lawrence; Zhou, Fang; Alvarez-Cardona, Jose; Reyentovich, Alex; Larson, Daniel; Maleszewski, Joseph; Sherrid, Mark

Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial

Mavacamten治疗有症状的梗阻性肥厚型心肌病患者心室应变的连续变化:来自VALOR-HCM试验的启示

Desai, Milind Y; Okushi, Yuichiro; Gaballa, Andrew; Wang, Qiuqing; Geske, Jeffrey B; Owens, Anjali T; Saberi, Sara; Wang, Andrew; Cremer, Paul C; Sherrid, Mark; Lakdawala, Neal K; Tower-Rader, Albree; Fermin, David; Naidu, Srihari S; Lampl, Kathy L; Sehnert, Amy J; Nissen, Steven E; Popovic, Zoran B